An Oklahoma reserve deputy pleaded not guilty on Tuesday in the death of a man he said he accidentally shot with a gun instead of a Taser, a Tulsa County District Court clerk said on Tuesday. Robert Bates, 73, an insurance executive who serves as a volunteer deputy with the Tulsa County Sheriff’s Office, has been charged with second-degree manslaughter in the April 2 death of Eric Harris, 44.
An Oklahoma reserve deputy pleaded not guilty on Tuesday in the death of a man he said he accidentally shot with a gun instead of a Taser, a Tulsa County District Court clerk said on Tuesday. Robert Bates, 73, an insurance executive who serves as a volunteer deputy with the Tulsa County Sheriff’s Office, has been charged with second-degree manslaughter in the April 2 death of Eric Harris, 44.
BRENHAM, Texas (AP) — Texas-based Blue Bell Creameries issued a voluntary recall Monday night for all of its products on the market after two samples of chocolate chip cookie dough ice cream tested positive for listeria, a potentially deadly bacteria.
BRENHAM, Texas (AP) — Texas-based Blue Bell Creameries issued a voluntary recall Monday night for all of its products on the market after two samples of chocolate chip cookie dough ice cream tested positive for listeria, a potentially deadly bacteria.
It’s April 20th or 4/20, a day when marijuana enthusiasts gather, legally or otherwise, to celebrate the joys of smoking pot.
It’s April 20th or 4/20, a day when marijuana enthusiasts gather, legally or otherwise, to celebrate the joys of smoking pot.
Hillary Clinton dismissed questions about her family foundation as political attacks.
Hillary Clinton dismissed questions about her family foundation as political attacks.
Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva’s cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan’s approach to Perrigo. Under the offer, Mylan shareholders would receive a premium
Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva’s cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan’s approach to Perrigo. Under the offer, Mylan shareholders would receive a premium
